Stocks
Cara Therapeutics (CARA) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -250.3 | 1.71 | 0.49 | -12.8 | 1.14 | -1 495 | ||
| Changes by years, y/y, % | -105% | -101% | -71% | -2 710% | -109% | -81.0% | |||
Cara Therapeutics. EV/EBITDA
Cara Therapeutics. EV/EBITDA, changes, %
Cara Therapeutics (CARA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.82 | 1.64 | 1.83 | 0.92 | 0.74 | -1 495 | |
| Changes by years, y/y, % | -2 975% | +259% | -128% | -106% | -113% | |||
| Changes by quarters, q/q, % | -62% | -128% | +11% | -50% | -19% | |||
